Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Cash from Financing Activities (2021 - 2025)

P3 Health Partners' Cash from Financing Activities history spans 5 years, with the latest figure at $12.9 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 61.82% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $72.8 million, down 26.28%, while the annual FY2025 figure was $72.8 million, 26.28% down from the prior year.
  • Cash from Financing Activities reached $12.9 million in Q4 2025 per PIIIW's latest filing, down from $14.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $87.2 million in Q2 2023 to a low of -$2.5 million in Q3 2024.
  • Average Cash from Financing Activities over 5 years is $15.4 million, with a median of $12.4 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: tumbled 5331.07% in 2022, then skyrocketed 7134.38% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $12.3 million in 2021, then rose by 21.97% to $15.0 million in 2022, then tumbled by 105.6% to -$840000.0 in 2023, then skyrocketed by 4113.93% to $33.7 million in 2024, then crashed by 61.82% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Cash from Financing Activities are $12.9 million (Q4 2025), $14.7 million (Q3 2025), and $14.6 million (Q2 2025).